Muna Bhanji - Apr 28, 2022 Form 3 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
Director
Signature
/s/ James Basta, Attorney-in-Fact
Stock symbol
NTLA
Transactions as of
Apr 28, 2022
Transactions value $
$0
Form type
3
Date filed
5/2/2022, 09:48 PM
Previous filing
Apr 1, 2022
Next filing
May 11, 2022

No securities are beneficially owned.

Remarks:

No Securities are beneficially owned.